This site does one thing: it turns the chaotic online market for weight loss medication into ranked, numbered lists a normal person can act on. That focus is deliberate. Since compounded GLP-1s arrived, dozens of telehealth programs have flooded search results and social feeds, all selling roughly two molecules — semaglutide and tirzepatide — at prices that differ by hundreds of dollars a month for reasons the ads never explain. Somebody has to sit down, pull every pricing page, decode every "from $99*" asterisk, and put the results in order. That is the job we picked.
The method, in one paragraph
Every provider we cover is scored against a fixed, published rubric — pricing transparency weighted heaviest, then realistic total cost, safety and sourcing disclosure, service terms, and reputation. The scores come from documented evidence: the provider's own published prices and policies, complaint records, and third-party review platforms. They do not come from us taking the medications, and no page on this site will ever suggest they do. The complete rubric, weights included, lives on the How We Rank page.
The four sections of the site
The Top 10 Rankings are the core product — ordered lists of programs, scored and re-verified on a cycle. The True Cost Guides follow each medication (Ozempic, Wegovy, Zepbound, Mounjaro, and their compounded counterparts) through every purchase route to a realistic dollar figure. The Brand Reviews are the full scorecards behind each ranked position. And the Learn section teaches the underlying medicine — mechanisms, dosing, side effects, compounding law — with primary-source citations and zero affiliate links.
The person doing the research
Content here is authored by Melissa Mathias, a registered dietitian licensed by the Indian Dietetic Association and the Dubai Health Authority, a Certified Diabetes Educator, and a clinician with more than ten years of experience in weight management, diabetes, and metabolic health — currently practicing at King's College Hospital Dubai. Her author page explains her background in full, including exactly how her name is used on this site and how content gets prepared under her direction.
The money, plainly
Affiliate commissions pay for this site. Sign up with certain providers through our links and they pay us; you pay nothing extra. That arrangement decides which companies we spend research hours on — it is barred from deciding scores or list positions, and several covered brands pay us nothing at all. The mechanics are laid out in our advertising disclosure, and the editorial policy lists the lines no commercial relationship is allowed to cross.
Rules we hold ourselves to
- The twelve-month price, not the teaser. If the bill doubles at month four, that fact leads.
- Compounded means not FDA-approved. We repeat that distinction everywhere it applies, without exception.
- No outcome guarantees. We quote cited clinical trial averages and stop there.
- Dates that mean something. A page's "last updated" date moves only when we actually re-verified it.
Found a stale price, a broken claim, or a provider we should cover? Write to us — corrections get read first.